B Bayrou

Unfractionated heparin and CY 216: pharmacokinetics and bioavailabilities of the antifactor Xa and IIa effects after intravenous and subcutaneous injection in the rabbit.

Laurence Briant, C. Caranobe, Sylvie Saivin et al. · PubMed · 1989 · 53 citations

Pharmacy, Pharmacokinetics, Pharmacology +9

Pharmacokinetic of a very low molecular weight heparin in chronic renal failure

B Hory, M.H. Claudet, J. Magnette et al. · Thrombosis Research · 1991 · 21 citations

Pharmacy, Pharmacokinetics, Pharmacology +14

Comparative Study on the Effects of a Low Molecular Weight Heparin (CY 216) and Standard Heparin in Low Dosage on Experimental Venous Thrombosis

C. Doutremepuich, F Bousquet, G.L. Gestreau et al. · Haemostasis · 2009 · 14 citations

Medicine, Hematology, Pharmacology +11

Low-Molecular-Weight Heparin Fraxiparin® in Chronic Hemodialysis

P. Morinière, J Diéval, B Bayrou et al. · Blood Purification · 2008 · 14 citations

Medicine, Hematology, Pharmacotherapy +14

The tPA-like activity induced by heparin and a heparin fragment binds on experimental thrombus

C. Doutremepuich, F Toulemonde, F. Doutremepuich et al. · Thrombosis Research · 1988 · 11 citations

Medicine, Biochemistry, Molecular Biology +16